Polymorphisms in genes HSD17B1 and HSD17B2 and uterine leiomyoma risk in Chinese women

Archives of Gynecology and Obstetrics

Volumn 286, Issue 3, 2012, Pages 701-705

  Cong, Rui Juan ^a   Huang, Zhong Ying ^a   Cong, Ling ^b   Ye, Yi ^a   Wang, Zheng ^a   Zha, Lagabaiyila ^a   Cao, Li Ping ^a   Su, Xiao Wei ^a   Yan, Jing ^a,c   Li, Ying Bi ^a  

^a SICHUAN UNIVERSITY   (China)

^b Shuangluan People's Hospital   (China)

^c Shanghai Key Laboratary of Forensic Medicine   (China)

Author keywords

HSD17B1; HSD17B2; SNPs; Uterine leiomyoma

Indexed keywords

ADENINE; GENOMIC DNA; GUANINE;

ADULT; ARTICLE; CARCINOGENESIS; CHINESE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HSD17B1 GENE; HSD17B2 GENE; HUMAN; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR GENE; UTERUS MYOMA;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; ESTRADIOL DEHYDROGENASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEIOMYOMA; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; UTERINE NEOPLASMS;

EID: 84867984828     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-012-2328-0     Document Type: Article

References (29)

1. Haney AF (2000) Clinical decision making regarding leiomyomata: What we need in the next millenium. Environ Health Perspect 108(Suppl 5):835-839
2. Lethaby A, Vollenhoven B (2005) Fibroids (uterine myomatosis, leiomyomas). Clin Evid (14):2264-2282
3. Maruo T, Ohara N, Wang J, Matsuo H (2004) Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum Reprod Update 10:207-220 (Pubitemid 38750141)
4. Walker CL, Stewart EA (2005) Uterine fibroids: The elephant in the room. Science 308:1589-1592 (Pubitemid 40807499)
5. Miettinen M, Mustonen M, Poutanen M, Isomaa V, Wickman M, Soderqvist G et al (1999) 17Beta-hydroxysteroid dehydrogenases in normal human mammary epithelial cells and breast tissue. Breast Cancer Res Treat 57:175-182 (Pubitemid 29531462)
6. Vihko P, Harkonen P, Soronen P, Torn S, Herrala A, Kurkela R et al (2004) 17Beta-hydroxysteroid dehydrogenases-their role in pathophysiology. Mol Cell Endocrinol 215:83-88
7. Jansson A, Gunnarsson C, Stal O (2006) Proliferative responses to altered 17beta-hydroxysteroid dehydrogenase (17HSD) type 2 expression in human breast cancer cells are dependent on endogenous expression of 17HSD type 1 and the oestradiol receptors. Endocr Relat Cancer 13:875-884 (Pubitemid 44763263)
8. Hsieh YY, Chang CC, Tsai FJ, Lin CC, Tsai CH (2008) T allele for VEGF-460 gene polymorphism at 50-untranslated region is associated with higher susceptibility of leiomyoma. Biochem Genet 46:356-361
9. Morikawa J, Yoshida S, Kennedy S, Takemura N, Sugimoto M, Kitao K et al (2008) Association study between catechol-Omethyltransferase polymorphisms and uterine leiomyomas in a Japanese population. Clin Exp Obstet Gynecol 35:35-40 (Pubitemid 351345814)
10. Villanova FE, Andrade PM, Otsuka AY, Gomes MT, Leal ES, Castro RA et al (2006) Estrogen receptor alpha polymorphism and susceptibility to uterine leiomyoma. Steroids 71:960-965 (Pubitemid 44573298)
11. Ye Y, Cheng X, Luo HB, Liu L, Li YB, Hou YP (2008) CYP1A1 and CYP1B1 genetic polymorphisms and uterine leiomyoma risk in Chinese women. J Assist Reprod Gen 25:389-394
12. Hsieh YY, Chang CC, Tsai FJ, Lin CC, Yeh LS, Peng CT (2004) Androgen receptor trinucleotide polymorphism in leiomyoma. J Assist Reprod Genet 21:453-457
13. Peltoketo H, Luu-The V, Simard J, Adamski J (1999) 17Betahydroxysteroid dehydrogenase (HSD)/17-ketosteroid reductase (KSR) family; nomenclature and main characteristics of the 17HSD/KSR enzymes. J Mol Endocrinol 23:1-11 (Pubitemid 29369554)
14. Mannermaa A, Peltoketo H, Winqvist R, Ponder BA, Kiviniemi H, Easton DF et al (1994) Human familial and sporadic breast cancer: Analysis of the coding regions of the 17 beta-hydroxysteroid dehydrogenase 2 gene (EDH17B2) using a single-strand conformation polymorphism assay. Hum Genet 93:319-324 (Pubitemid 24066935)
15. Normand T, Narod S, Labrie F, Simard J (1993) Detection of polymorphisms in the estradiol 17 beta-hydroxysteroid dehydrogenase II gene at the EDH17B2 locus on 17q11-q21. Hum Mol Genet 2:479-483 (Pubitemid 23107230)
16. Lamp M, Peters M, Reinmaa E, Haller-Kikkatalo K, Kaart T, Kadastik U et al (2011) Polymorphisms in ESR1, ESR2 and HSD17B1 genes are associated with fertility status in endometriosis. Gynecol Endocrinol 27:425-433
17. Katoh T, Tsuchiya M, Nakao H, Sasaki H, Hiroshima M, Tanaka T et al (2005) Association between endometriosis and genetic polymorphisms of the estradiol-synthesizing enzyme genes HSD17B1 and CYP19. Hum Reprod 20:974-978 (Pubitemid 40667843)
18. Lee IW, Kuo PH, Su MT, Kuan LC, Hsu CC, Kuo PL (2011) Quantitative trait analysis suggests polymorphisms of estrogenrelated genes regulate human sperm concentrations and motility. Hum Reprod 26:1585-1596
19. Sainz J, Rudolph A, Hein R, Hoffmeister M, Buch S, von Schonfels W et al (2011) Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk. Endocr Relat Cancer 18:265-276
20. Feigelson HS, Cox DG, Cann HM, Wacholder S, Kaaks R, Henderson BE et al (2006) Haplotype analysis of the HSD17B1 gene and risk of breast cancer: A comprehensive approach to multicenter analyses of prospective cohort studies. Cancer Res 66:2468-2475
21. Kraft P, Pharoah P, Chanock SJ, Albanes D, Kolonel LN, Hayes RB et al (2005) Genetic variation in the HSD17B1 gene and risk of prostate cancer. PLoS Genet 1:e68
22. Husen B, Psonka N, Jacob-Meisel M, Keil C, Rune GM (2000) Differential expression of 17 beta-hydroxysteroid dehydrogenases types 2 and 4 in human endometrial epithelial cell lines. J Mol Endocrinol 24:135-144 (Pubitemid 30117667)
23. Yang SJ, Fang ZJ, Gurates B, Tamura M, Miller J, Ferrer K et al (2001) Stromal PRs mediate induction of 17 beta-hydroxysteroid dehydrogenase type 2 expression in human endometrial epithelium: A paracrine mechanism for inactivation of E2. Mol Endocrinol 15:2093-2105 (Pubitemid 33141129)
24. Andersson S,MoghrabiN(1997) Physiology andmolecular genetics of 17 beta-hydroxysteroid dehydrogenases. Steroids 62:143-147 (Pubitemid 27066998)
25. Moghrabi N, Head JR, Andersson S (1997) Cell type-specific expression of 17 beta-hydroxysteroid dehydrogenase type 2 in human placenta and fetal liver. J Clin Endocr Metab 82:3872-3878 (Pubitemid 27509385)
26. Elo JP, Harkonen P, Kyllonen AP, Lukkarinen O, Poutanen M, Vihko R et al (1997) Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer. Cancer Res 57:3356-3359 (Pubitemid 27355474)
27. Kuo PL, Su MT, Chen CH, Kuo PH, Hsu CC, Lee IW et al (2010) Polymorphisms of estrogen-related genes jointly confer susceptibility to human spermatogenic defect. Fertil Steril 93:141-149
28. Warren R, Skinner J, Sala E, Denton E, Dowsett M, Folkerd E et al (2006) Associations among mammographic density, circulating sex hormones, and polymorphisms in sex hormone metabolism genes in postmenopausal women. Cancer Epidemiol Biomarkers 15:1502-1508 (Pubitemid 44299323)
29. Karageorgi S, McGrath M, Lee IM, Buring J, Kraft P, De Vivo I (2011) Polymorphisms in genes hydroxysteroid-dehydrogenase-17b type 2 and type 4 and endometrial cancer risk. Gynecol Oncol 121:54-58